阿姆洛迪平在当前高血压的管理中
Ji-Guang Wang1, Biff F Palmer2, Katherine Vogel Anderson3
1The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Journal of clinical hypertension (Greenwich, Conn.)
|August 8, 2023
概括
阿姆洛迪平有效地控制高血压,为30多年提供持续的血压控制和心血管保护. 这种通道阻塞剂是各种患者群体的经济有效的治疗选择.
科学领域:
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學.
背景情况:
- 高血压是全球主要的死亡原因,影响全球14亿人.
- 通道阻塞剂是常见的高血压治疗方法,阿姆洛迪平表现出明显的特征.
- 对阿姆洛迪平30年来证据的审查对于当前高血压管理至关重要.
研究的目的:
- 为了提供过去30年来关于阿姆洛迪平的证据的最新概述.
- 突出阿姆洛迪平在当代高血压管理中的心血管益处.
- 评估阿姆洛迪平在不同患者群体中的疗效和安全性.
主要方法:
- 审查现有的文学和临床证据关于阿姆洛迪平.
- 分析阿姆洛迪平的药理动力学特性 (低清除,长半衰期).
- 在各种患者群体中评估安洛迪平对血压变化和控制的影响.
主要成果:
- 阿姆洛迪平提供持续24小时的抗高血压效果,并保持血压控制,即使错过了剂量.
- 它有效降低血压变化,并控制高血压,糖尿病或慢性病患者的血压,而不会对血糖或功能产生不良影响.
- 氨基显示出显著的心血管保护,降低中风和心肌梗塞的风险,特别是在老年人中.
结论:
- 阿姆洛迪平是一种有价值的抗高血压剂,具有独特的药理动力学特性和已证明的心血管益处.
- 它在广泛的患者中提供可靠的血压控制和保护,包括那些患有并发症的患者.
- 阿姆洛迪平是一种高血压的经济有效的治疗选择,与常规护理相比,有可能节省成本.
相关概念视频
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
14
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
14
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
511
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
511
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
463
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
463
01:23Hypertension V: Nursing Management
11
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
11
01:18Antihypertensive Drugs: Action of Calcium Channel Blockers
568
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
568
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
780
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
780